Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Biotech
Teva brings biotech ethos to drug development, exec says
“We’re a big company, but we really treat our innovative medicines in a real biotech way," Teva's CMO, Eric Hughes, M.D., Ph.D., told Fierce Biotech.
Fraiser Kansteiner
Oct 15, 2024 4:33pm
Inflammation-focused Upstream to join trickle of biotech IPOs
Sep 19, 2024 4:50am
GSK's long-acting asthma drug halved attacks in phase 3
Sep 9, 2024 9:30am
Connect reduces China workforce, mulls strategy for asthma drug
Sep 6, 2024 4:37am
Ethris' inhaled mRNA asthma drug safely boosts target protein
Jun 28, 2024 7:25am
GSK's SWIFT trials show long-acting treatment reduces attacks
May 21, 2024 2:00am
